ASX:MVPPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
Medical Developments International Ltd
$0.465
+$0.005 (+1.09%)
Day Range
$0.460 – $0.470
52 Week Range
$0.365 – $0.765
Volume
28.65K
Avg Volume (10D)
70.09K
Market Cap
$52.39M
P/E Ratio
571.43
Price Chart
Market Statistics
Open$0.460
Previous Close$0.460
Day High$0.470
Day Low$0.460
52 Week High$0.765
52 Week Low$0.365
Valuation
Market Cap52.39M
Shares Outstanding112.66M
P/E Ratio (Annual)571.43
Price to Book0.99
Trading Activity
Volume28.65K
Value Traded13.29K
Bid$0.460 × 34,933
Ask$0.465 × 2,723
Performance
1 Day0.00%
5 Day0.00%
13 Week9.09%
52 Week-35.14%
YTD-13.51%
Technical Indicators
RSI (14)53.90
50-Day SMA$0.422
200-Day SMA$0.462
Latest News
Biotechnology
Medical Developments International Achieves Positive Cash Flow in Strong Q3 Performance
Medical Developments International posts strong Q3 FY26: revenue $10.5m up 19%, positive cash flow and progress on European paediatric Penthrox approvals.
Biotechnology
Medical Developments strikes deal with Daiichi Sankyo to export Penthrox green whistle to China
Medical solutions company Medical Developments International (ASX: MVP) has set out intentions to expand its market presence by signing an exclusive distribution and license agreement with Tokyo-listed Daiichi Sankyo for its Penthrox drug in China, Thailand and Vietnam. According to the terms of the deal, Daiichi Sankyo will pay Medical Developments as much as US$32.5 […]